Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer

10.1007/s00280-012-1895-x

Saved in:

Bibliographic Details
Main Authors:	Farid, M., Chowbay, B., Chen, X., Tan, S.H., Ramasamy, S., Koo, W.H., Toh, H.C., Choo, S.P., Ong, S.Y.K.
Other Authors:	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
Format:	Article
Published:	2016
Subjects:	Chronomodulated Colorectal cancer Dose-intensified Phase I XELOX
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/124814
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-124814
record_format	dspace
spelling	sg-nus-scholar.10635-1248142024-11-09T20:13:28Z Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer Farid, M. Chowbay, B. Chen, X. Tan, S.H. Ramasamy, S. Koo, W.H. Toh, H.C. Choo, S.P. Ong, S.Y.K. DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE Chronomodulated Colorectal cancer Dose-intensified Phase I XELOX 10.1007/s00280-012-1895-x Cancer Chemotherapy and Pharmacology 70 1 141-150 CCPHD 2016-06-01T10:30:25Z 2016-06-01T10:30:25Z 2012-07 Article Farid, M., Chowbay, B., Chen, X., Tan, S.H., Ramasamy, S., Koo, W.H., Toh, H.C., Choo, S.P., Ong, S.Y.K. (2012-07). Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer. Cancer Chemotherapy and Pharmacology 70 (1) : 141-150. ScholarBank@NUS Repository. https://doi.org/10.1007/s00280-012-1895-x 03445704 http://scholarbank.nus.edu.sg/handle/10635/124814 000306803600016 Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	Chronomodulated Colorectal cancer Dose-intensified Phase I XELOX
spellingShingle	Chronomodulated Colorectal cancer Dose-intensified Phase I XELOX Farid, M. Chowbay, B. Chen, X. Tan, S.H. Ramasamy, S. Koo, W.H. Toh, H.C. Choo, S.P. Ong, S.Y.K. Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer
description	10.1007/s00280-012-1895-x
author2	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
author_facet	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE Farid, M. Chowbay, B. Chen, X. Tan, S.H. Ramasamy, S. Koo, W.H. Toh, H.C. Choo, S.P. Ong, S.Y.K.
format	Article
author	Farid, M. Chowbay, B. Chen, X. Tan, S.H. Ramasamy, S. Koo, W.H. Toh, H.C. Choo, S.P. Ong, S.Y.K.
author_sort	Farid, M.
title	Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer
title_short	Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer
title_full	Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer
title_fullStr	Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer
title_full_unstemmed	Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer
title_sort	phase i pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (xelox) in metastatic colorectal cancer
publishDate	2016
url	http://scholarbank.nus.edu.sg/handle/10635/124814
_version_	1821226829677068288

Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer

Similar Items